Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Lipids Health Dis. 2014 Jan 6;13:4. doi: 10.1186/1476-511X-13-4.
The aim of this study was to estimate the prevalence, awareness, treatment, and control of dyslipidemia in Xinjiang, China.
Stratified sampling method was used to select a representative sample of the general population including Chinese Han, Uygur, and Kazak in this geographic area. Seven cities were chosen. Based on the government records of registered residences, one participant was randomly selected from each household. The eligibility criterion for the study was ≥ 35 years of age.
A total of 14,618 participants (5,757 Han, 4,767 Uygur, and 4,094 Kazak), were randomly selected from 26 villages in 7 cities. The prevalence of dyslipidemia was 52.72% in the all participants. The prevalence of dyslipidemia was higher in Han than that in the other two ethnic (58.58% in Han, 48.27% in Uygur, and 49.60% in Kazak, P < 0.000). The prevalence of dyslipidemia was higher in men than that in women (56.4% vs. 49.3%, P < 0.000). Among the participants with dyslipidemia, the proportion of those who aware, treat, control of dyslipidemia were 53.67%, 22.51%, 17.09% in Han, 42.19%, 27.78%, 16.20% in Uygur, 37.02%, 21.11%, 17.77% in Kazak.
Dyslipidemia is highly prevalent in Xinjiang. The proportion of participants with dyslipidemia who were aware, treated, and controlled is unacceptably low. These results underscore the urgent need to develop national strategies to improve the prevention, detection, and treatment of dyslipidemia in Xinjiang.
本研究旨在评估中国新疆地区血脂异常的患病率、知晓率、治疗率和控制率。
采用分层抽样方法，选择该地理区域的汉族、维吾尔族和哈萨克族普通人群的代表性样本。选择了七个城市。根据政府登记的常住户口记录，从每个家庭中随机选择一名参与者。研究的入选标准为年龄≥35 岁。
共从 7 个城市的 26 个村庄中随机抽取了 14618 名参与者（汉族 5757 名、维吾尔族 4767 名和哈萨克族 4094 名）。所有参与者中血脂异常的患病率为 52.72%。汉族的血脂异常患病率高于其他两个民族（汉族为 58.58%，维吾尔族为 48.27%，哈萨克族为 49.60%，P<0.000）。男性血脂异常的患病率高于女性（56.4%比 49.3%，P<0.000）。在血脂异常的参与者中，汉族、维吾尔族和哈萨克族知晓、治疗和控制血脂异常的比例分别为 53.67%、22.51%和 17.09%、42.19%、27.78%和 16.20%、37.02%、21.11%和 17.77%。
血脂异常在新疆地区患病率较高。血脂异常患者中知晓、治疗和控制的比例低得令人无法接受。这些结果突显出迫切需要制定国家战略，以改善新疆血脂异常的预防、检测和治疗。
